XML 18 R8.htm IDEA: XBRL DOCUMENT v3.21.1
UNAUDITED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Earnings
Balance beginning of period (in shares) at Dec. 31, 2019   55,798      
Balance beginning of period at Dec. 31, 2019 $ 1,269,813 $ 558 $ 644,412 $ (210,051) $ 834,894
Increase (Decrease) in Stockholders' Equity          
Net income 11,572       11,572
Other comprehensive (loss) income (59,306)     (59,306)  
Stock-based compensation 3,291   3,291    
Issuance of common stock for restricted share vesting, net of employee tax withholdings (in shares)   59      
Issuance of common stock for restricted share vesting, net of employee tax withholdings (2,224) $ 1 (2,225)    
Repurchases of common stock (in shares)   (302)      
Repurchases of common stock (17,341) $ (3) (17,338)    
Balance ending of period (in shares) at Mar. 31, 2020   55,555      
Balance ending of period at Mar. 31, 2020 1,205,805 $ 556 628,140 (269,357) 846,466
Balance beginning of period (in shares) at Dec. 31, 2020   54,773      
Balance beginning of period at Dec. 31, 2020 1,341,551 $ 548 582,749 (211,477) 969,731
Increase (Decrease) in Stockholders' Equity          
Net income 21,736       21,736
Other comprehensive (loss) income 11,948     11,948  
Stock-based compensation 3,480   3,480    
Issuance of common stock for restricted share vesting, net of employee tax withholdings (in shares)   78      
Issuance of common stock for restricted share vesting, net of employee tax withholdings (3,719) $ 1 (3,720)    
Repurchases of common stock (in shares)   (300)      
Repurchases of common stock (26,546) $ (3) (26,543)    
Balance ending of period (in shares) at Mar. 31, 2021   54,551      
Balance ending of period at Mar. 31, 2021 $ 1,348,450 $ 546 $ 555,966 $ (199,529) $ 991,467